How is Dexmedetomidine (Oromucosal Route) dosed?
Not specified
What is the dosage form of Dexmedetomidine (Oromucosal Route)?
The dosage forms of dexmedetomidine for oromucosal route are film. The film is placed either under the tongue (sublingual) or behind the lower lip (buccal) until it is dissolved. The patient should not eat or drink anything for at least 1 hour after taking the medicine and should not chew or swallow the film.
What medications are contraindication with Dexmedetomidine (Oromucosal Route)?
Dexmedetomidine should not be used with certain medications such as bepridil, cisapride, dronedarone, mesoridazine, pimozide, piperaquine, saquinavir, sparfloxacin, terfenadine, thioridazine, and ziprasidone. Consult a doctor for further information and advice on drug interactions and contraindications.
How is Dexmedetomidine (Oromucosal Route) administered?
Dexmedetomidine is administered by a nurse or other trained health professional in a medical facility. It comes in the form of a film that is given either under the tongue (sublingual) or behind the lower lip (buccal). Avoid eating or drinking for at least 1 hour after taking the medicine, and do not chew or swallow the film.
What are common precautions when taking Dexmedetomidine (Oromucosal Route)?
Common precautions when taking dexmedetomidine oromucosal route include:
- Not eating or drinking anything for at least 1 hour after taking the medicine.
- Not chewing or swallowing the sublingual film; instead, place it under the tongue until it is dissolved. Do not eat or drink anything for at least 15 minutes after taking the medicine.
- Informing your doctor of any allergies, previous reactions to medicines, or other types of allergies.
- Checking with your doctor about potential interactions with other medications or supplements.
- Monitoring your heart rhythm and reporting any changes or issues.
- Informing your doctor if you have a history of heart rhythm problems.
- Undergoing regular check-ups with your doctor. Following these precautions can help ensure the safe and effective use of dexmedetomidine oromucosal route.